Gufic Biosciences deepens global oncology push with fresh investment in Australia’s Selvax
Selvax, founded in 1987, is focused on developing novel immunotherapy solutions with applications in both human and veterinary oncology
Selvax, founded in 1987, is focused on developing novel immunotherapy solutions with applications in both human and veterinary oncology
Rahul Bhatnagar succeeds Aditya Narayan, who completed a decade-long distinguished tenure
Patalganga plant received zero observation from USFDA earlier
SRM Medical College Hospital and Research Centre hosts undergraduate research expo highlighting innovation, interdisciplinary collaboration, and the role of artificial intelligence
Patients, doctors, and caregivers come together to promote awareness, early intervention, and pain-free living
Experts call for integrated, evidence-based approaches to tackle rising dengue, malaria, and chikungunya burden in Indian cities
Acquisition to expand the company's women’s health and biosimilars footprint, positioning it among top 25 drugmakers globally
The move brings one of the country’s most widely prescribed blood thinners onto Cost Plus Drug Company’s online pharmacy platform
The webinar series will showcase next-gen imaging technologies, global expert insights, and hands-on sessions on microscopy innovations
The capacity addition to be implemented in a phased manner amid evolving business and market dynamics
Subscribe To Our Newsletter & Stay Updated